Weil Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,250
Closed -$208K 152
2023
Q1
$208K Buy
+3,250
New +$212K 0.09% 132
2022
Q4
Sell
-3,250
Closed -$229K 145
2022
Q3
$229K Hold
3,250
0.14% 107
2022
Q2
$231K Hold
3,250
0.13% 111
2022
Q1
$260K Hold
3,250
0.13% 112
2021
Q4
$297K Hold
3,250
0.14% 112
2021
Q3
$418K Buy
+3,250
New +$455K 0.22% 85

Other funds holding STAA

Weil Company's STAA Position: Q2 2023 in Review

Weil Company sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 3,250 shares — an estimated $208K sold.

Weil Company first reported a position in STAA in Q3 2021 and held it in 6 quarters. The position peaked at $418K in Q3 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Weil Company reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Weil Company sold 3,250 STAAR Surgical shares in Q2 2023, an estimated $208K.
  • Weil Company first reported a position in STAAR Surgical in Q3 2021 and held it in 6 quarters.
  • Weil Company's STAAR Surgical position peaked at $418K in Q3 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Weil Company's 13F filing for Q2 2023, filed 8 Aug 2023.